MIRIAM DUNN: Open Payments
NPI 1962960021 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,403 in 59 payments from 25 companies in 2025. Trend: 2023 $254 · 2024 $202 · 2025 $1,403
Food & beverage: $1,109Education: $294
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $173 |
| Exelixis Inc. | 2 | $119 |
| Daiichi Sankyo Inc. | 5 | $108 |
| Janssen Biotech, Inc. | 6 | $107 |
| SEAGEN INC. | 1 | $100 |
| Genentech USA, Inc. | 4 | $91 |
| Merck Sharp & Dohme LLC | 4 | $85 |
| PFIZER INC. | 7 | $74 |
| Karyopharm Therapeutics Inc. | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $57 |
Products named: VENCLEXTA, Enhertu, KEYTRUDA, XPOVIO, TALVEY, Itovebi, REBLOZYL, Orserdu.
Industry payments across TX — which companies pay providers there.
